SCHEMBL1028638

SCHEMBL1028638

C=CC(=O)OCCOC(=O)CP(=O)(C(=O)c1c(C)cc(C)cc1C)C(=O)c1c(C)cc(C)cc1C

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.40
TSHR P16473 6/20 0.38
ALDH1A1 P00352 3/20 0.38
TP53 P04637 2/20 0.38
HIF1A Q16665 2/20 0.38
HSD17B10 Q99714 1/20 0.38
HPGD P15428 2/20 0.36
CYP3A4 P08684 1/20 0.35
KDM4E B2RXH2 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
CRHR1 P34998 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1035772 0.82 ALDH1A1 (0.37) THRBTSHRALDH1A1HSD17B10HPGD
SCHEMBL1028591 0.82 THRB (0.38) THRBTSHRALDH1A1HPGDKDM4E
SCHEMBL1038469 0.82 CRHR1 (0.34) TSHRHPGDCYP3A4KDM4EL3MBTL1
SCHEMBL2886656 0.82 CRHR1 (0.34) TSHRHPGDCYP3A4KDM4EL3MBTL1
SCHEMBL1039014 0.81 NLRP3 (0.44) TSHRALDH1A1HSD17B10HPGDCYP3A4
SCHEMBL1034149 0.81 HTR1A (0.35) HPGDKDM4EL3MBTL1MEN1LMNA
SCHEMBL1037680 0.81 HTR1A (0.35) HPGDKDM4EL3MBTL1MEN1LMNA
SCHEMBL1038151 0.81 HTR1A (0.35) HPGDKDM4EL3MBTL1MEN1LMNA
SCHEMBL1036934 0.80 KDM4E (0.36) HPGDKDM4EL3MBTL1MEN1LMNA
SCHEMBL1033698 0.80 TAS1R3 (0.39) HPGDMEN1LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451847-B1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES IGM GROUP B V (NL) 2021-11-24 EP disclosed
US-9120900-B2 Polymer-bound bisacylphosphine oxides BASF SE (DE) 2015-09-01 US disclosed
US-20150025169-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES BASF SE (DE) 2015-01-22 US disclosed
US-8883872-B2 Polymer-bound bisacylphosphine oxides BASF SE (DE) 2014-11-11 US disclosed
US-20120142805-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES BASF SE (DE) 2012-06-07 US disclosed
EP-2451847-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES BASF SE (DE) 2012-05-16 EP disclosed
WO-2011003772-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES BASF SE (DE) 2011-01-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142805-A1 POLYMER-BOUND BISACYLPHOSPHINE OXIDES PHOSPHO1, PARG, PEBP1 THRB 4336/4885TSHR 4599/4885ALDH1A1 4528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.